Cargando…
Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
Understanding the pathophysiology and genetic background of Parkinson’s disease (PD) increases the likelihood of developing effective disease-modifying therapeutic strategies. In particular, the discovery of genetic variants causing or increasing the risk for PD has contributed to refining the clini...
Autores principales: | Straccia, Giulia, Colucci, Fabiana, Eleopra, Roberto, Cilia, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599944/ https://www.ncbi.nlm.nih.gov/pubmed/36291241 http://dx.doi.org/10.3390/brainsci12101308 |
Ejemplares similares
-
Unraveling Autonomic Dysfunction in GBA‐Related Parkinson's Disease
por: Devigili, Grazia, et al.
Publicado: (2023) -
Telemedicine for parkinsonism: A two-step model based on the COVID-19 experience in Milan, Italy
por: Cilia, Roberto, et al.
Publicado: (2020) -
Personalized medicine in Parkinson's disease: Time to be precise
por: Titova, Nataliya, et al.
Publicado: (2017) -
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
por: Morgante, Francesca, et al.
Publicado: (2020) -
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
por: Schneider, Susanne A., et al.
Publicado: (2020)